Экспериментальные модели рестриктивной кардиомиопатии
https://doi.org/10.24884/1682-6655-2015-14-3-14-21
Аннотация
Об авторах
М. М. Галагудза
Северо-Западный федеральный медицинский исследовательский центр; Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Россия
А. А. Костарева
Северо-Западный федеральный медицинский исследовательский центр; Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Россия
Список литературы
1. Bartfay W.J., Bartfay E. Iron-overload cardiomyopathy. Evidence for a free radical-mediated mechanism of injury and dysfunction in a murine model // Biol. Res. Nurs. 2000. № 2 (1). Р. 49-59.
2. Bartfay W.J., Dawood F., Wen W.H. et al. Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload // Cardiovasc. Res. 1999. № 43 (4). Р. 892-900.
3. Bashey R.I., Philips N., Insinga F., Jimenez S.A. Increased collagen synthesis and increased content of type vi collagen in myocardium of tight skin mice // Cardiovasc. Res. 1993. № 27. Р. 1061-1065.
4. Boerma M., Hauer-Jensen M. Preclinical research into basic mechanisms of radiation-induced heart disease // Cardiol. Res. Pract. 2011. Р. 858-862.
5. Boerma M., Roberto K.A., Hauer-Jensen M. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol // Int. J. Radiat. Oncol. Biol. Phys. 2008. № 72 (1). Р. 170-177.
6. Boerma M., Wang J., Wondergem J. et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease // Cancer Res. 2005. № 65 (8). Р. 3100-3107.
7. Borgna-Pignatti C., Rugolotto S., De Stefano P. et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine // Haematologica. 2004. № 89. Р. 1187-1193.
8. Brewer C.J., Wood R.I., Wood J.C. mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload // Exp. Hematol. 2014. № 42 (12). Р. 1059-1067.
9. Burke W., Thomson E., Khoury M. et al. Hereditary hemochromatosis. Gene discovery and its implications for population-based screening // JAMA. 1998. № 280. Р. 172-178.
10. Buxbaum J., Tagoe C., Gallo G. et al. The pathogenesis of transthyretin tissue deposition. Р. lessons from transgenic mice // Amyloid. 2003. № 10 (S1). Р. 2-6.
11. Davis J., Yasuda S., Palpant N.J. et al. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy // J. Mol. Cell. Cardiol. 2012. № 53 (3). Р. 446-457.
12. DiBartola S.P., Tarr M.J., Benson M.D. Tissue distribution of amyloid deposits in Abyssinian cats with familial amyloidosis // J. Comp. Pathol. 1986. № 96 (4). Р. 387-398.
13. Du J., Liu J., Feng H. Z. et al. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI // Am. J. Physiol. Heart Circ. Physiol. 2008. № 294. Р. H2604- H2613.
14. Du J., Zhang C., Liu J. et al. A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice // Arch. Biochem. Biophys. 2006. № 456 (2). Р. 143-150.
15. Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases // Eur. Heart J. 2008. № 29 (2). Р. 270-276.
16. Fox P.R., Basso C., Thiene G., Maron B.J. Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease // Cardiovasc. Pathol. 2014. № 23 (1). Р. 28-34.
17. Gutierrez L., Quintana C., Patino C. et al. Iron speciation study in Hfe knockout mice tissues. Magnetic and ultrastructural characterization // Biochim. Biophys. Acta. 2009. № 1792. Р. 541-547.
18. Hirasawa M., Ito Y., Shibata M. A., Otsuki Y. Mechanism of inflammation in murine eosinophilic myocarditis produced by adoptive transfer with ovalbumin challenge // Int. Arch. Allergy Immunol. 2007. № 142 (1). Р. 28-39.
19. Houser S.R., Margulies K.B., Murphy A.M. et al. Animal models of heart failure: a scientific statement from the American Heart Association // Circ. Res. 2012. № 111 (1). Р. 131-150.
20. Huang F.W., Pinkus J.L., Pinkus G.S. et al. A mouse model of juvenile hemochromatosis // J. Clin. Invest. 2005. № 115. Р. 2187-2191.
21. Huby A.C., Mendsaikhan U., Takagi K. et al. Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy // J. Am. Coll. Cardiol. 2014. № 64 (25). Р. 2765-2776.
22. Kaiser L., Davis J., Patterson J. et al. Iron does not cause arrhythmias in the guinea pig model of transfusional iron overload // Comp. Med. 2007. № 57 (4). Р. 383-389.
23. Kostareva A., Gudkova A., Sjoberg G. et al. Deletion in TNNI3 gene is associated with restrictive cardiomyopathy // Int. J. Cardiol. 2009. № 131 (3). Р. 410-412.
24. Kostareva A., Gudkova A., Sjoberg G. et al. Desmin mutations in a St. Petersburg cohort of cardiomyopathies // Acta Myol. 2006. № 25 (3). Р. 109-115.
25. Kushwaha S.S., Fallon J.T., Fuster V. Restrictive cardiomyopathy // N. Engl. J. Med. 1997. № 336 (4). Р. 267-276.
26. Li M., Andersson-Lendahl M., Sejersen T., Arner A. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment // FASEB J. 2014. № 28(4). Р. 1593-1599. doi. Р. 10.1096/fj. 13-240044. Epub 2013 Dec 26.
27. Li Y., Zhang L., Jean-Charles P. Y. et al. Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations // J. Mol. Cell. Cardiol. 2013. № 62. Р. 227-236.
28. Liu S. K., Tilley L. P Animal models of primary myocardial diseases // Yale J. Biol. Med. 1980. № 53. Р. 191-211.
29. Maisch B., Noutsias M., Ruppert V. et al. Cardiomyopathies: classification, diagnosis, and treatment // Heart Fail. Clin. 2012. № 8 (1). Р. 53-78.
30. Menon S.C., Michels V.V., Pellikka P.A. et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology // Clin. Genet. 2008. № 74. Р. 445-454.
31. Mogensen J., Kubo T., Duque M. et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations // J. Clin. Invest. 2003. № 111. Р. 209-216.
32. Mogensen J., Murphy R.T., Shaw T. et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy // J. Am. Coll. Cardiol. 2004. № 44. Р. 2033-2040.
33. Nakamura S., Okabayashi S., Ageyama N. et al. Transthyretin amyloidosis and two other aging-related amyloidoses in an aged vervet monkey // Vet Pathol. 2008. № 45. Р. 67-72.
34. Nick H., Allegrini P.R., Fozard L. et al. Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis // Exp. Biol. Med. (Maywood). 2009. № 234. Р. 492-503.
35. Peddy S. B., Vricella L. A., Crosson J. E. et al. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin Tgene // Pediatrics. 2006. № 117. Р. 1830-1833.
36. Pruszczyk P., Kostera-Pruszczyk A., Shatunov A. et al. Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation // Int. J. Cardiol. 2007. № 117. Р. 244-253.
37. Purevjav E., Arimura T., Augustin S. et al. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations // Hum. Mol. Genet. 2012. № 21. Р. 2039-2053.
38. Schwartz K.A., Fisher J., Adams E. T. Morphologic investigations of the guinea pig model of iron overload // Toxicol. Pathol. 1993. № 21 (3). Р. 311-320.
39. Stefanelli C.B., Rosenthal A., Borisov A.B. et al. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity // Mol. Genet. Metab. 2004. № 83. Р. 188-196.
40. Taunk N.K., Haffty B.G., Kostis J.B., Goyal S. Radiation-induced heart disease // Pathologic abnormalities and putative mechanisms. Front Oncol. 2015. № 5. Р. 39.
41. Tilley L.P., Liu S.K., Gilbertson S.R. et al. Primary myocardial disease in the cat. A model for human cardiomyopathy // Am. J. Pathol. 1977. № 86. P 493-522.
42. Viswanathan M.C., Kaushik G., Engler A.J. et al. Drosophila melanogaster model of diastolic dysfunction and cardiomyopathy based on impaired troponin-T function // Circ. Res. 2014. № 114 (2). P. e6-e17.
43. Wen Y., Xu Y., Wang Y. et al. Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice // J. Mol. Biol. 2009. № 392. P. 1158-1167.
44. Wood J.C., Otto-Duessel M., Gonzalez I. et al. Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil // Transl. Res. 2006. № 148 (5). P. 272-280.
45. Yamada M., Kotani Y., Nakamura K. et al. Immunohistochemical distribution of amyloid deposits in 25 cows diagnosed with systemic AA amyloidosis // J. Vet. Med. Sci. 2006. № 68. P. 725-729.
46. Yarom R., Harper I.S., Wynchank S. et al. Effect of captopril on changes in rats' hearts induced by long-term irradiation // Radiat. Res. 1993. № 133 (2). P. 187-197.
47. Zhang J., Kumar A., Stalker H. J. et al. Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy // Clin. Genet. 2001. № 59 (4). P. 248-256.
48. Zhang Z., Hsieh B., Poe A. et al. Complex genetic architecture of cardiac disease in a wild type inbred strain of Drosophila melanogaster // PLoS One. 2013. № 8 (4). P. e62909.
Рецензия
Для цитирования:
Галагудза М.М., Костарева А.А. Экспериментальные модели рестриктивной кардиомиопатии. Регионарное кровообращение и микроциркуляция. 2015;14(3):14-21. https://doi.org/10.24884/1682-6655-2015-14-3-14-21
For citation:
Galagudza M.M., Kostareva A.A. Experimental models of restrictive cardiomyopathy. Regional blood circulation and microcirculation. 2015;14(3):14-21. (In Russ.) https://doi.org/10.24884/1682-6655-2015-14-3-14-21
Просмотров: 766
Послать статью по эл. почте 
